Ralf Ewert Selected Research

Iloprost (Ventavis)

1/2022	Strategies for optimizing intravenous prostacyclin-analog therapy in patients with pulmonary arterial hypertension.
10/2021	Digital Tracking of Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Observational Study (VENTASTEP).
1/2019	Intravenous treprostinil via an implantable pump in pediatric pulmonary arterial hypertension.
12/2011	Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy.
4/2011	Inhaled iloprost for therapy in pulmonary arterial hypertension.
5/2010	Long-term therapy with inhaled iloprost in patients with pulmonary hypertension.
12/2008	Iloprost in pulmonary hypertension.
6/2007	Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost.
4/2007	Continuous intravenous iloprost to revert treatment failure of first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension.
1/2007	Effect of inhaled iloprost during off-medication time in patients with pulmonary arterial hypertension.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ralf Ewert Research Topics

Disease

29	Pulmonary Arterial Hypertension 10/2022 - 02/2002
25	Pulmonary Hypertension 10/2022 - 05/2003
10	Familial Primary Pulmonary Hypertension 10/2022 - 09/2005
6	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 03/2009
5	Heart Failure 07/2020 - 03/2007
5	Body Weight (Weight, Body) 01/2020 - 03/2007
4	Lung Diseases (Lung Disease) 10/2022 - 03/2009
3	Apnea 12/2021 - 11/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 05/2014
2	Dyspnea (Shortness of Breath) 10/2021 - 01/2019
2	Obesity 12/2020 - 01/2019
2	Diabetes Mellitus 12/2020 - 08/2011
2	Disease Progression 01/2019 - 04/2007
2	Infections 10/2018 - 03/2017
2	Inflammation (Inflammations) 01/2017 - 02/2009
2	Hemoptysis 01/2017 - 12/2008
2	Cardiotoxicity 03/2015 - 11/2007
2	Cardiomyopathies (Cardiomyopathy) 03/2015 - 11/2007
2	Thrombosis (Thrombus) 11/2012 - 12/2008
2	Asthma (Bronchial Asthma) 01/2011 - 10/2009
2	Neoplasms (Cancer) 04/2010 - 02/2009
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2021
1	Myocardial Infarction 01/2021
1	Hypertension (High Blood Pressure) 12/2020
1	Coronary Disease (Coronary Heart Disease) 12/2020
1	Diastolic Heart Failure 07/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2019
1	Obstructive Sleep Apnea 10/2019
1	Restless Legs Syndrome (Restless Legs) 01/2019
1	Systemic Scleroderma (Systemic Sclerosis) 01/2019
1	Fatigue 01/2019
1	Sepsis (Septicemia) 10/2018
1	Pulmonary Embolism 01/2018
1	Aspergillosis 01/2018
1	Disorders of Excessive Somnolence (Hypersomnia) 11/2016
1	Sleepiness 11/2016
1	Sleep Initiation and Maintenance Disorders (Insomnia) 11/2016
1	Sleep Apnea Syndromes (Sleep Apnea) 11/2016
1	Mental Disorders (Mental Disorder) 08/2013
1	Periodontal Diseases (Periodontal Disease) 01/2013
1	Catheter-Related Infections 11/2012

Drug/Important Bio-Agent (IBA)

12	Iloprost (Ventavis)FDA Link 01/2022 - 09/2005
8	Oxygen (Dioxygen)IBA 01/2022 - 03/2007
8	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2022 - 02/2006
7	treprostinil FDA Link 01/2022 - 03/2017
4	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2022 - 06/2005
4	Clostridium perfringens epsilon-toxinIBA 01/2022 - 01/2011
4	Endothelin Receptor AntagonistsIBA 01/2020 - 10/2005
4	Bosentan (Tracleer)FDA Link 01/2019 - 10/2005
4	Pharmaceutical PreparationsIBA 01/2019 - 11/2007
4	ProstaglandinsIBA 10/2017 - 12/2008
4	Endothelin Receptors (Endothelin Receptor)IBA 03/2015 - 10/2005
3	Biomarkers (Surrogate Marker)IBA 12/2020 - 05/2014
3	Endothelin-1 (Endothelin 1)IBA 03/2015 - 06/2005
2	Carbon MonoxideIBA 10/2022 - 12/2020
2	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 12/2015
2	GoldIBA 01/2022 - 12/2016
2	Sildenafil Citrate (Viagra)FDA Link 01/2019 - 05/2003
2	riociguatIBA 01/2019 - 01/2017
2	Carbon DioxideIBA 01/2018 - 01/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2015 - 11/2007
1	Complement System Proteins (Complement)IBA 10/2021
1	selexipagIBA 02/2021
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2021
1	tetramethrinIBA 01/2021
1	InsecticidesIBA 01/2021
1	cypermethrin (alphamethrin)IBA 01/2021
1	Piperonyl Butoxide FDA Link 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020
1	Soluble Guanylyl CyclaseIBA 01/2020
1	Phosphodiesterase 5 InhibitorsIBA 01/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2019
1	Biological ProductsIBA 01/2019
1	Antidepressive Agents (Antidepressants)IBA 01/2019
1	CytokinesIBA 01/2019
1	MagnesiumIBA 01/2019
1	Voriconazole (Vfend)FDA LinkGeneric 01/2018
1	Fibrinogen (Factor I)FDA Link 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	hydroxide ionIBA 01/2017
1	Vitamin D FDA LinkGeneric 01/2017
1	Dehydroepiandrosterone (DHEA)IBA 11/2016
1	Estradiol (Delestrogen)FDA LinkGeneric 11/2016
1	Estrone FDA Link 11/2016
1	Androstenedione (4 Androstene 3,17 dione)IBA 11/2016
1	AndrogensIBA 11/2016
1	C-terminal proendothelin-1IBA 12/2015
1	BQ 788IBA 03/2015
1	Tuberculin (PPD)IBA 01/2013

Therapy/Procedure

35	Therapeutics 10/2022 - 09/2005
4	Lung Transplantation 01/2022 - 12/2002
3	Catheters 10/2018 - 11/2007
2	Cardiac Catheters 07/2020 - 12/2006
1	Nebulizers and Vaporizers (Inhaler) 10/2021
1	Implantable Infusion Pumps 01/2020
1	Infusion Pumps (Infusion Pump) 01/2019
1	Decompression 01/2018
1	General Anesthesia 03/2017
1	Glycemic Control 01/2017
1	Drug Therapy (Chemotherapy) 08/2015